QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=86EE8D8B6B703E6EEBA3A5B918311149;jsessionid=721D62B3A270ACC6D9EF9470B56D2FF2;jsessionid=777569317CCAAF6560E300AE323F785B;jsessionid=0B26DA522EF2C3E6BD93409E647D84F3;jsessionid=4D2CAEDC9B56FE167FEBBDBA88D962F7;jsessionid=E06368E43757C652CD3C9A7F75FA1024;jsessionid=83508DB128333FF041C5D61C4AD58758;jsessionid=170F843E6B9CF11ECAC90B44E9C31B4A (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=86EE8D8B6B703E6EEBA3A5B918311149;jsessionid=721D62B3A270ACC6D9EF9470B56D2FF2;jsessionid=777569317CCAAF6560E300AE323F785B;jsessionid=0B26DA522EF2C3E6BD93409E647D84F3;jsessionid=4D2CAEDC9B56FE167FEBBDBA88D962F7;jsessionid=E06368E43757C652CD3C9A7F75FA1024;jsessionid=83508DB128333FF041C5D61C4AD58758;jsessionid=170F843E6B9CF11ECAC90B44E9C31B4A